Healthcare Provider Attitudes of Safety of Intrauterine Devices in the Postpartum Period
- PMID: 27992305
- PMCID: PMC11025292
- DOI: 10.1089/jwh.2016.5985
Healthcare Provider Attitudes of Safety of Intrauterine Devices in the Postpartum Period
Abstract
Objective: Immediate postpartum intrauterine devices (IUDs) have been underutilized in the United States despite their known safety. Understanding how providers' attitudes contribute to underutilization is important in improving access. Our objective was to examine healthcare providers' perceptions of the safety of immediate postpartum IUDs before publication of United States contraceptive guidelines.
Materials and methods: We analyzed survey data collected from December 2009 to March 2010 from 635 office-based physicians and 1368 Title X clinic providers (overall response rate of 64.8%). Providers were asked how safe they thought copper and levonorgestrel (LNG) IUDs were in postpartum women (very safe, safe, unsafe, very unsafe, and unsure). Multivariable logistic regression was used to calculate adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs) for characteristics associated with considering immediate and delayed postpartum IUDs to be safe.
Results: Less than 40% of respondents considered immediate or delayed IUD insertion to be safe. Providers with <1 day of family planning training had decreased odds of considering immediate postpartum IUD insertion to be safe compared with unsafe/unsure (aOR 0.18, 95% CI 0.04-0.84 for copper IUD and aOR 0.17, 95% CI 0.04-0.81 for LNG-IUD). Providers without training in postpartum or interval copper IUD insertion had decreased odds of considering immediate postpartum copper IUD insertion (aOR 0.40, 95% CI 0.16-0.79) and delayed postpartum insertion for both IUD types to be safe (aOR 0.34, 95% CI 0.18-0.66 for copper IUD and aOR 0.41, 95% CI 0.21-0.77 for LNG-IUD).
Conclusions: Before United States contraceptive guidelines, a majority of providers perceived immediate postpartum IUDs to be unsafe.
Keywords: contraception; intrauterine devices; postpartum; providers.
Conflict of interest statement
Author Disclosure Statement
No competing financial interests exist.
Similar articles
-
Health care provider attitudes and practices related to intrauterine devices for nulliparous women.Obstet Gynecol. 2012 Apr;119(4):762-71. doi: 10.1097/AOG.0b013e31824aca39. Obstet Gynecol. 2012. PMID: 22433340
-
Healthcare Provider Attitudes Regarding Contraception for Women with Obesity.J Womens Health (Larchmt). 2017 Aug;26(8):870-877. doi: 10.1089/jwh.2016.5930. Epub 2017 Jan 31. J Womens Health (Larchmt). 2017. PMID: 28140761 Free PMC article.
-
Intrauterine devices. The optimal long-term contraceptive method?J Reprod Med. 1999 Mar;44(3):269-74. J Reprod Med. 1999. PMID: 10202746 Review.
-
Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.Contraception. 2015 Apr;91(4):280-3. doi: 10.1016/j.contraception.2015.01.011. Epub 2015 Jan 16. Contraception. 2015. PMID: 25601350 Clinical Trial.
-
Intrauterine Device Insertion and Removal.Prim Care. 2021 Dec;48(4):531-544. doi: 10.1016/j.pop.2021.07.001. Epub 2021 Oct 7. Prim Care. 2021. PMID: 34752267 Review.
Cited by
-
Long-Acting Reversible Contraception Initiation With a 2- to 3-Week Compared With a 6-Week Postpartum Visit.Obstet Gynecol. 2017 Oct;130(4):788-794. doi: 10.1097/AOG.0000000000002246. Obstet Gynecol. 2017. PMID: 28885429 Free PMC article. Clinical Trial.
-
State-Identified Implementation Strategies to Increase Uptake of Immediate Postpartum Long-Acting Reversible Contraception Policies.J Womens Health (Larchmt). 2019 Mar;28(3):346-356. doi: 10.1089/jwh.2018.7083. Epub 2018 Nov 2. J Womens Health (Larchmt). 2019. PMID: 30388052 Free PMC article.
-
Client and provider factors associated with integration of family planning services among maternal and reproductive health clients in Kigoma Region, Tanzania: a cross-sectional study, April-July 2016.Reprod Health. 2018 Sep 12;15(1):152. doi: 10.1186/s12978-018-0593-5. Reprod Health. 2018. PMID: 30208913 Free PMC article.
References
-
- CDC. Postpartum care visits—11 states and New York City, 2004. MMWR 2007;56:1312–1316. - PubMed
-
- CDC. U.S. Medical eligibility criteria for contraceptive use, 2010. MMWR 2010;59:1–84. - PubMed
-
- American College of Obstetricians and Gynecologists. Long-acting reversible contraceptives and intrauterine devices. Practice Bulletin No. 121. Obstet Gynecol 2011;118:184–196. - PubMed
-
- Moniz MH, Dalton VK, Davis MM, et al. Characterization of Medicaid policy for immediate postpartum contraception. Contraception 2015;92:523–531. - PubMed
-
- Whiteman MK, Cox S, Tepper NK, et al. Postpartum intrauterine device insertion and postpartum tubal sterilization in the United States. Am J Obstet Gynecol 2012;206:e1–e7. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical